Allurion Technologies (ALURD) Other Non-Current Liabilities (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Other Non-Current Liabilities came in at $5.1 million in Q1 2026, down 44.99% YoY from $9.3 million in Q1 2025, and up 1223.64% on a QoQ basis from $385000.0 in Q4 2025.
Allurion Technologies (ALURD) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 44.99% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 44.99% YoY) and the FY2025 annual result came in at $385000.0, up 2164.71% from the prior year.
- Other Non-Current Liabilities climbed to $5.1 million in Q1 2026, from $385000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $12.0 million in Q3 2023 to a low of $17000.0 in Q4 2024.
- A 5-year average of $5.4 million and a median of $5.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities surged 2904.5% — and 2024, when it plunged 99.8%.
- Tracing ALURD's Other Non-Current Liabilities over 5 years: stood at $2.6 million in 2022, then surged by 226.26% to $8.3 million in 2023, then sank by 99.8% to $17000.0 in 2024, then surged by 2164.71% to $385000.0 in 2025, then surged by 1223.64% to $5.1 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $5.1 million (Q1 2026), $385000.0 (Q4 2025), and $816000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 385,000.00 |
| Sep 30, 2025 | 816,000.00 |
| Jun 30, 2025 | 926,000.00 |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 9.87 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 8.32 Mn |
| Sep 30, 2023 | 12.02 Mn |
| Jun 30, 2023 | 10.88 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 400,000.00 |